Acute hepatitis C virus infection: Diagnosis, pathogenesis, treatment

Journal of Gastrointestinal and Liver Diseases

Volumn 15, Issue 3, 2006, Pages 249-256

  Cǎruntu, Florin Alexandru ^a,b   Benea, Loredana ^b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Matei Bals Infectious Diseases Institute   (Romania)

Author keywords

Acute hepatitis; Diagnosis, treatment; HCV; Immune response

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; PEGINTERFERON; RIBAVIRIN;

ACUTE HEPATITIS; ANTIBODY BLOOD LEVEL; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; ENZYME IMMUNOASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; META ANALYSIS; MONOTHERAPY; PATHOGENESIS; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA VIRUS; SYSTEMATIC REVIEW; T LYMPHOCYTE; VIREMIA;

HEPATITIS C; HUMANS;

EID: 33749259433     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Alter HJ. HCV natural history: The retrospective and prospective in perspective. J Hepatol 2005; 43: 550-552.
2. Vogt M, Lang T, Frosner G et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening. N Engl J Med 1999; 341:866-870.
3. Rodger AJ, Roberts S, Lanigan A et al. Assessment of long term outcomes of community acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000; 32: 582-587.
4. Mondelli MU, Cerino A, Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol 2005; 42 Suppl(9):S108-14
5. Craxi A, Licata A. Acute hepatitis C: in search of the optimal approach to cure. Hepatology 2006; 43: 221-224.
6. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis 2005; 25: 7-17.
7. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321-327.
8. Wedemeyer H, Jackel E, Wiegand J et al. Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C. Hepatology 2004; 39: 1201-1203.
9. Lu SN, Tung HD, Chen TM et al. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti HCV titre rather than by seroconversion? J Viral Hepat 2004; 11: 563-570.
10. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36 (5, suppl.1): S21-S29.
11. Pawlotski JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36 (5, suppl.1): S65-S73.
12. Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol 2003; 38: S104-S118.
13. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229.
14. Murkherjee S. Pathophysiology and immunology of disease response. E- Medicine. Hepatitis C Feature Series Newsletter: 1-5.
15. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003; 38: 4-13.
16. Sarobe P, Lasarte JJ, Garcia N et al. Characterization of T- cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins. J Viral Hepat 2006: 47-55
17. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004; 24 (suppl.2): 3-8.
18. Pham TN, MacParland SA Mulrooney PM et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004; 78: 5867-5874.
19. Farci P, Shimoda A, Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288: 339-344.
20. Sarobe P. Can VHC subvert dendritic cell function? EASL Postgraduate Course. Vienna, Austria, April 26-27, 2006:25-29.
21. Polyak P. Innate intracellular defense against HCV and its modulation by HCV gene products. EASL Postgraduate Course. Vienna, Austria, April 26-27, 2006: 30-33.
22. Perelson AS, Herrmann E, Micol F et al. New kinetic models for the hepatitis C virus. Hepatology 2005; 42: 749-754.
23. Lutchman G, Hoofnagle J. Viral kinetics in hepatitis C. Hepatology 2003; 37: 1257-1259.
24. Herrmann E, Lee JH., Marinos G et al. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Hepatology 2003; 37: 1351-1358.
25. 4+T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632-638.
26. 4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002; 123: 1070-1083.
27. Diepolder HM. Interferon-alpha for hepatitis C: antiviral or immunotherapy? J Hepatol 2004; 40: 1030-1031.
28. Wiegand J, Jackel E, Cornberg M et al. Long term follow up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40: 98-107.
29. Hofer H, Watkins-Riedel T, Janata O et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003; 37: 60-64.
30. Zekry A, Patel K, McHutchison JG. Treatment of acute hepatitis C infection: more pieces of the puzzle? J Hepatol 2005; 42: 293-296.
31. Alberti A, Boccato S, Vario A et al. Therapy of acute hepatitis C. Hepatology 2002; 36 (5 suppl.1): S195-S200.
32. Dienstag JL, McHutchison JG. American Gastroenterological Association. Technical review on the management of hepatitis C. Gastroenterology 2006;130:231-264.
33. Piasecki BA, Reddy KR, Chang KM. Acute hepatitis C: To treat or not to treat? Hepatology 2002; 35: 1538-1540.
34. Licata A, Di Bona D, Schepis F et al. When and how to treat acute hepatitis C? J Hepatol 2003; 39: 1056-1062.
35. Nomura H, Sou S, Tanimoto H et al. Short-term interferon-alpha therapy for acute hepatitis C: a randomized controlled trial. Hepatology 2004; 39: 1213-1219.
36. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006;13:34-41
37. Kamal SM, Ismail A, Graham CS et al. Pegylated interferon-alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology 2004; 39 1721-1731.
38. Berg T, Pascu M, Moller B. Prediction of spontaneous viral clearance in acute hepatitis C by viral load measurements. Hepatology 2003; 37: 1495-1496.
39. Strader DB, Wright T, Thomas DL et al. Diagnosis, management and treatment of hepatitis C. Hepatology 2004; 39: 1147-1171.
40. Kamal SM, Moustafa KN, Chen J et al. Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology 2006; 43:923-931.